Allworth Financial’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
Other funds holding BBH
MIM
CCA
BFG
Allworth Financial's BBH Position: Q2 2026 in Review
Allworth Financial reduced its VanEck Biotech ETF (BBH) stake by 72% in Q2 2026, selling an estimated $57.5K and leaving 120 shares worth $24.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3042.
Allworth Financial first reported a position in BBH in Q2 2020 and has held it in 24 quarters since. The position peaked at $80.6K in Q4 2025. 110 funds tracked by Wall St. Rank hold BBH as of Q2 2026.
- Allworth Financial held 120 shares of VanEck Biotech ETF worth $24.4K as of Q2 2026.
- Allworth Financial sold 306 VanEck Biotech ETF shares in Q2 2026, an estimated $57.5K.
- VanEck Biotech ETF made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3042 holding.
- Allworth Financial first reported a position in VanEck Biotech ETF in Q2 2020 and has held it in 24 quarters since.
- Allworth Financial's VanEck Biotech ETF position peaked at $80.6K in Q4 2025.
- 110 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.
Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.